Brief: Anika Receives FDA 510(K) Clearance For The X-Twist Knotless Fixation System
20/05/2022 14:20
May 20 (Reuters) - Anika Therapeutics Inc ANIK.O :
* ANIKA RECEIVES FDA 510(K) CLEARANCE FOR THE X-TWIST™
KNOTLESS
FIXATION SYSTEM, EXPANDING ITS SPORTS MEDICINE SOFT TISSUE
PORTFOLIO
* ANIKA THERAPEUTICS INC - EXPECTS TO BEGIN COMMERCIALIZING
X-TWIST KNOTLESS FIXATION SYSTEM IN SECOND HALF OF 2022 WITHIN
UNITED STATES
Source text for Eikon: ID:nGNX17Zn61
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%